Insider · CIK 0001382629
Marc Belsky
Files at KZR (Kezar Life Sciences, Inc.). First filing -, latest -.
Marc Belsky files SEC Form 4 as CFO at KZR (Kezar Life Sciences, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Marc Belsky has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 15 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 11, 2026 | KZR Kezar Life Sciences, Inc. | UTender of shares Common Stock | -1,538 | - | - | 0 | May 11, 2026 |
| May 11, 2026 | KZR Kezar Life Sciences, Inc. | UTender of shares Common Stockindirect: By Trust | -200 | - | - | 0 | May 11, 2026 |
| May 11, 2026 | KZR Kezar Life Sciences, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -17,793 | $0.00 | $0 | 0 | May 11, 2026 |
| May 11, 2026 | KZR Kezar Life Sciences, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -29,499 | $0.00 | $0 | 0 | May 11, 2026 |
| May 11, 2026 | KZR Kezar Life Sciences, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -24,500 | $0.00 | $0 | 0 | May 11, 2026 |
| May 11, 2026 | KZR Kezar Life Sciences, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -12,000 | $0.00 | $0 | 0 | May 11, 2026 |
| May 11, 2026 | KZR Kezar Life Sciences, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -5,999 | $0.00 | $0 | 0 | May 11, 2026 |
| May 11, 2026 | KZR Kezar Life Sciences, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -5,999 | $0.00 | $0 | 0 | May 11, 2026 |
| May 11, 2026 | KZR Kezar Life Sciences, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -8,999 | $0.00 | $0 | 0 | May 11, 2026 |
| May 11, 2026 | KZR Kezar Life Sciences, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -21,999 | $0.00 | $0 | 0 | May 11, 2026 |
| May 11, 2026 | KZR Kezar Life Sciences, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -13,999 | $0.00 | $0 | 0 | May 11, 2026 |
| May 11, 2026 | KZR Kezar Life Sciences, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -19,499 | $0.00 | $0 | 0 | May 11, 2026 |
| Mar 27, 2025 | KZR Kezar Life Sciences, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +4,800 | $0.00 | $0 | 12,000 | Apr 1, 2025 |
| Mar 4, 2025 | KZR Kezar Life Sciences, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +7,200 | $0.00 | $0 | 7,200 | Mar 5, 2025 |
| Jan 9, 2025 | KZR Kezar Life Sciences, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +24,500 | $0.00 | $0 | 24,500 | Jan 13, 2025 |
Questions about Marc Belsky
Answered from the filings on this page, as of the latest one.
Is Marc Belsky buying or selling?
Marc Belsky has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Marc Belsky's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Marc Belsky has 0.
Where does Marc Belsky file Form 4?
Marc Belsky has filed Form 4 at KZR (Kezar Life Sciences, Inc.) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.